Exploring the Intersection of Law, Clinical Practice & Ethical Standards with Limited Resources

Exploring the Intersection of Law, Clinical Practice & Ethical Standards with Limited Resources 

This webinar will address the complexity of two increasingly common interventions: emotional-support animals and leaves of absence. 

Session Information 

Format: Self-paced, recorded webinar
Original Recording Date: October 1, 2020 

Release Date: October 1, 2020  
Expiration Date: October 1, 2022  
After the expiration date, this webinar will no longer be accessible for viewing or downloading.
CE Credit must be requested by the expiration date.

Cost: 
$25 for ACHA individual members
$50 for nonmembers

Fees are nonrefundable.

Speaker(s)

Danielle Oakley, PhD 
Oakley & Associates Consulting, LLC

Allen Kropp, JD
Drummond Woodsum

Intended Audience

• Administrator
• Advanced Practice Clinicians
• Mental Health Professional
• Psychiatrist 

Learning Objectives

After this session, participants should be able to: 

1. Discuss ethical, legal, and federal guideline implications for requests for emotional-support animal documentation and leaves of absence participation.
2. Describe current practice options for emotional-support animal documentation requests and participation in leaves of absence processes.

Program Planning Committee

Resolution of Potential Conflicts of Interest — Program Planning Committee
Committee members have completed conflict of interest statements regarding relationships with commercial entities. Each of the Program Planning Committee members have reported no relevant financial conflicts of interest.

• Education Planning Committee Roster

Credit and Disclosures

Types of Credit Available

Refer to the Continuing Education Key.

• CME: 1.5  
• PsyCE: 1.5

Instructions for Obtaining Credit (or certificate of attendance)

Select the "Contents" tab above (registered users only) for access to the following components. It is estimated that it will require one hour to view the webinar and complete the post-test. Credit must be requested by the program expiration date (see "Overview" tab above).

Step 1:  View the webinar video in its entirety.

Step 2:  Complete the mandatory Post-test for CE Credit.

Step 3:  Select the certificate for the type of credit you are requesting. Select "Certificate of Attendance" if no credit is being requested. 

Statements and Disclosures

Continuing Education 

The American College Health Association (ACHA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

ACHA designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim credit commensurate with the extent of their participation in the activity.

ACHA is approved by the American Psychological Association to sponsor continuing education for psychologists. ACHA maintains responsibility for this program and its content. This program has been awarded 1.5 hour of continuing education for psychologists.

Successful Completion/Post Test
It is the policy of the American College Health Association that when a post-test is required upon completion of a continuing education activity, participants must receive a passing grade of 80%. If participants receive a grade lower than 80%, they will be given the opportunity to re-take the post-test one time. If they receive 80% or higher the second time, they will be awarded continuing education credits/contact hours for the activity. We encourage participants to complete the post-test immediately after viewing the download.

Conflicts of Interest
A conflict of interest occurs when an individual has an opportunity to affect educational content about health-care products or services of a commercial company with which she/he has a financial relationship.

All planners and presenters of this activity have disclosed no relevant financial relationships with any commercial companies pertaining to this activity.

Off-Label Product Use
This educational activity does not include any unannounced information about off-label use of a product for a purpose other than that for which it was approved by the Food and Drug Administration (FDA).